Literature DB >> 24929003

DOK3 is required for IFN-β production by enabling TRAF3/TBK1 complex formation and IRF3 activation.

Susana Soo-Yeon Kim1, Koon-Guan Lee2, Ching-Siang Chin2, Say-Kong Ng2, Natasha Ann Pereira2, Shengli Xu2, Kong-Peng Lam3.   

Abstract

The downstream of kinase (DOK) family of adaptors is generally involved in the negative regulation of signaling pathways. DOK1, 2, and 3 were shown to attenuate TLR4 signaling by inhibiting Ras-ERK activation. In this study, we elucidated a novel role for DOK3 in IFN-β production. Macrophages lacking DOK3 were impaired in IFN-β synthesis upon influenza virus infection or polyinosinic-polyribocytidylic acid stimulation. In the absence of DOK3, the transcription factor IFN regulatory factor 3 was not phosphorylated and could not translocate to the nucleus to activate ifn-β gene expression. Interestingly, polyinosinic-polyribocytidylic acid-induced formation of the upstream TNFR-associated factor (TRAF) 3/TANK-binding kinase (TBK) 1 complex was compromised in dok3(-/-) macrophages. DOK3 was shown to bind TBK1 and was required for its activation. Furthermore, we demonstrated that overexpression of DOK3 and TBK1 could significantly enhance ifn-β promoter activity. DOK3 was also shown to bind TRAF3, and the binding of TRAF3 and TBK1 to DOK3 required the tyrosine-rich C-terminal domain of DOK3. We further revealed that DOK3 was phosphorylated by Bruton's tyrosine kinase. Hence, DOK3 plays a critical and positive role in TLR3 signaling by enabling TRAF3/TBK1 complex formation and facilitating TBK1 and IFN regulatory factor 3 activation and the induction of IFN-β production.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24929003     DOI: 10.4049/jimmunol.1301601

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  The stress granule protein G3BP1 binds viral dsRNA and RIG-I to enhance interferon-β response.

Authors:  Susana Soo-Yeon Kim; Lynette Sze; ChengCheng Liu; Kong-Peng Lam
Journal:  J Biol Chem       Date:  2019-02-25       Impact factor: 5.157

2.  Dok3-protein phosphatase 1 interaction attenuates Card9 signaling and neutrophil-dependent antifungal immunity.

Authors:  Jia Tong Loh; Shengli Xu; Jian Xin Huo; Susana Soo-Yeon Kim; Yue Wang; Kong-Peng Lam
Journal:  J Clin Invest       Date:  2019-06-10       Impact factor: 14.808

3.  Docking protein-1 promotes inflammatory macrophage signaling in gastric cancer.

Authors:  Tong Li; Beifang Li; Asgharpour Sara; Christine Ay; Wing Yan Leung; Yanquan Zhang; Yujuan Dong; Qiaoyi Liang; Xiang Zhang; Philip Weidner; Tobias Gutting; Hans-Michael Behrens; Christoph Röcken; Joseph Jy Sung; Matthias P Ebert; Jun Yu; Elke Burgermeister
Journal:  Oncoimmunology       Date:  2019-08-21       Impact factor: 8.110

4.  PLA1A Participates in the Antiviral Innate Immune Response by Facilitating the Recruitment of TANK-Binding Kinase 1 to Mitochondria.

Authors:  Xiaoxiao Gao; Dan Chen; Xue Hu; Yuan Zhou; Yun Wang; Chunchen Wu; Jizheng Chen; Yanyi Wang; Rongjuan Pei; Xinwen Chen
Journal:  J Innate Immun       Date:  2018-07-17       Impact factor: 7.349

5.  TRAF3: a novel tumor suppressor gene in macrophages.

Authors:  Almin I Lalani; Chang Luo; Yeming Han; Ping Xie
Journal:  Macrophage (Houst)       Date:  2015-09-30

6.  Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.

Authors:  Ke-Qiong Deng; Aibing Wang; Yan-Xiao Ji; Xiao-Jing Zhang; Jing Fang; Yan Zhang; Peng Zhang; Xi Jiang; Lu Gao; Xue-Yong Zhu; Yichao Zhao; Lingchen Gao; Qinglin Yang; Xue-Hai Zhu; Xiang Wei; Jun Pu; Hongliang Li
Journal:  Nat Commun       Date:  2016-06-01       Impact factor: 14.919

7.  TANK-Binding Kinase 1 (TBK1) Isoforms Negatively Regulate Type I Interferon Induction by Inhibiting TBK1-IRF3 Interaction and IRF3 Phosphorylation.

Authors:  Yi Wei Hu; Jie Zhang; Xiao Man Wu; Lu Cao; Pin Nie; Ming Xian Chang
Journal:  Front Immunol       Date:  2018-01-30       Impact factor: 7.561

8.  A functional genomics predictive network model identifies regulators of inflammatory bowel disease.

Authors:  Lauren A Peters; Jacqueline Perrigoue; Arthur Mortha; Alina Iuga; Won-Min Song; Eric M Neiman; Sean R Llewellyn; Antonio Di Narzo; Brian A Kidd; Shannon E Telesco; Yongzhong Zhao; Aleksandar Stojmirovic; Jocelyn Sendecki; Khader Shameer; Riccardo Miotto; Bojan Losic; Hardik Shah; Eunjee Lee; Minghui Wang; Jeremiah J Faith; Andrew Kasarskis; Carrie Brodmerkel; Mark Curran; Anuk Das; Joshua R Friedman; Yoshinori Fukui; Mary Beth Humphrey; Brian M Iritani; Nicholas Sibinga; Teresa K Tarrant; Carmen Argmann; Ke Hao; Panos Roussos; Jun Zhu; Bin Zhang; Radu Dobrin; Lloyd F Mayer; Eric E Schadt
Journal:  Nat Genet       Date:  2017-09-11       Impact factor: 38.330

9.  SHP-1 suppresses the antiviral innate immune response by targeting TRAF3.

Authors:  Doudou Hao; Yu Wang; Liuyan Li; Gui Qian; Jing Liu; Manman Li; Yihua Zhang; Ruixue Zhou; Dapeng Yan
Journal:  FASEB J       Date:  2020-07-23       Impact factor: 5.191

Review 10.  Genetic Alterations of TRAF Proteins in Human Cancers.

Authors:  Sining Zhu; Juan Jin; Samantha Gokhale; Angeli M Lu; Haiyan Shan; Jianjun Feng; Ping Xie
Journal:  Front Immunol       Date:  2018-09-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.